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PREDICTORS OF HAVING HPV VACCINATION AMONG YOUNG
ADULTS : A BRFSS 2014 STUDY
Deborah Kanda B.Pharm; Kelly Sullivan, PhD; and Robert Vogel PhD, MA
INTRODUCTION
 Human Papillomavirus (HPV) is the most common sexually
transmitted infection in the United States (1) with nearly all
sexually active men and women contracting at least one form
of it in their lifetime (2). HPV can cause health problems
including genital warts and cancers such as cervical cancer,
oropharyngeal cancer and cancers of the vulva, vagina, penis
or anus (2)

PUBLIC HEALTH IMPLICATIONS

RESULTS
Descriptive statistics of the study population, BRFSS 2014

 HPV infection and cervical cancer disproportionately affect
minority women (9). Efforts to increase vaccination among
minority groups have the potential to reduce disparities in
HPV-related diseases and cancers

 According to the CDC, an estimated 79 million Americans
have HPV and about 14 million become newly infected
annually (2). About 74% of new infections occur in those aged
15-24 years (3)

STRENTHS & LIMITATIONS
 Strengths:
 The BRFSS sample size was large and allowed for a
comprehensive analysis of the data

 Vaccination has been found to lower the risk of HPV infection
(4). The Advisory Committee on Immunization Practices
recommend routine HPV vaccination for all 11 and 12-year
olds (5). However, HPV vaccination rates lag behind compared
to other recommended vaccines for young adults (5)
 Several studies have investigated the reasons for low HPV
vaccinations and the most common cited reasons for not
vaccinating were “not recommended/needed”, “not sexually
active” and “safety concerns/side effects” (6). Other reasons
include financial concerns, low perceived risk of HPV
infection, irregular preventive care, social influences and
parental attitudes and concerns about the vaccine’s effect on
sexual behavior (7)
 There is a need to better understand social factors that are
predictive of vaccination among young adults

 The study participants were from the community and
extended beyond clinical populations to achieve a true
representation of study participants
 Limitations:
 Self-reported responses
 The study only considered responses to ever had the HPV
vaccine and not on the completion rates

CONCLUSION

Table showing results from logistic regression analysis
Variable
Odds ratio

95% Confidence Limits

Age in years (25-34)

(0.23, 0.36)

0.29

PURPOSE
 Objective: To evaluate the association of social determinants
of health on HPV vaccination rates among adults between the
ages of 18-34 years

METHODS
 Data from the 2014 Behavioral Risk Factor Surveillance
System (BRFSS) were used for this study. The 8 states (AL, DE,
GA, IN, MA, MN, RI, and WY) that included the HPV
vaccination module in their survey were included in the
analyses
 There were 8,050 adults aged 18-34 years that gave valid
response when asked “Have you ever had the HPV
vaccination?”. This was categorized into “yes” and “no”
responses and used as the dependent variable
 Social factors such as age, sex, race and ethnicity, education
attainment, marital status, health insurance, PAP screening,
metropolitan status and cigarette smoking were considered
 SAS 9.4 SURVEYFREQ and SURVEYLOGISTIC regression
analyses were used to assess the relationship between HPV
vaccination status and the socio-demographic factors

 It is imperative to improve HPV vaccination rates by focusing
on high-risk populations to prevent disparities in cervical
cancer and other cancers that are associated with HPV
infection

Race (Black vs White)

0.54

(0.40, 0.73)

Race (Other vs White)

0.57

(0.44, 0.74)

Insurance (yes)

1.71

(1.28, 2.29)

Education (>HS)

1.70

(1.36, 2.11)

Marital status (single)

2.06

(1.64, 2.59)

Metropolitan status
(urban)

1.93

(1.23, 3.04)

Smoking status (yes)

0.87

(0.69, 1.09)

PAP test (yes)

1.67

(1.26, 2.20)

 Among adults aged 18-34 years, younger age, female sex,
white race, having health insurance, higher education,
metropolitan residence, being unmarried, and having had
pap test were found to be associated with increasing odds of
receiving the HPV vaccination
 Focused educational efforts should target older adolescents,
including males and other racial groups. These efforts should
facilitate increase in HPV vaccination rates
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